Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Business Model:
Revenue: $0
Employees: 11-50
Address: 953 Indiana Street
City: San Francisco
State: CA
Zip: 94107
Country: US
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Seed Round | 3 | $10M |
Bold Capital Partners Humboldt Fund Owl Capital Bold Capital Partners Humboldt Fund Owl Capital |
6/2019 | Seed Round | 4 | $6.5M |
8VC CRV Presight Capital The Longevity Fund 8VC CRV Presight Capital The Longevity Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|